跳至主要内容
临床试验/ACTRN12615000904572
ACTRN12615000904572已完成未知

For pregnant women with a first trimester HbA1c in the pre-diabetes range, does intensive management including blood sugar monitoring to maintain normoglycaemia, compared to standard weight gain and dietary advice, improve pregnancy outcome. A feasibility trial for PINTO.

Ruth Hughes0 个研究点目标入组 150 人开始时间: 2015年8月31日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
16 Years 至 o limit(—)
性别
Female

入选标准

  • Women with an HbA1c level of 41-46mmol/mol and who are <14 weeks’ gestation with an ongoing pregnancy.

排除标准

  • Women with HbA1c levels greater than or equal to 47mmol/mol. Women with known diabetes. Women carrying a fetus with a known lethal congenital anomaly and / or an abnormal karyotype / chromosomal abnormality. Women planning to terminate the pregnancy. Women taking metformin to manage pre-diabetes or polycystic ovarian syndrome will be excluded from the study and referred to the local antenatal diabetes clinic, or be advised to have an early 75g oral glucose tolerance test (OGTT) depending on local policy.

研究者

发起方
Ruth Hughes

相似试验